Vascular endothelial growth factor and its type 2 receptor in tumors and serum of patients with renal cancer
β Scribed by N. E. Kushlinsky; M. F. Trapeznikova; E. S. Gershtein; P. A. Glibin; I. A. Kazantceva; M. B. Kilichbekov
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 221 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Vascular endothelial growth factor (VEGF) expression seems to be associated with worse overall survival in patients with head and neck squamous cell carcinoma. The purposes of this study were to assess the prognostic values of the immunohistochemical expression of VEGF an
It is known that vascular endothelial growth factor (VEGF) family is an important role in vasculogenesis and angiogenesis. Among the VEGF family members, VEGF-A plays an essential role in angiogenesis. However, the significance of serum levels of other VEGF members (VEGF-C and -D) has been reported
## Abstract ## Background Vascular endothelial growth factor (VEGF) is recognized as an important stimulator of angiogenesis. Formation of new blood vessels by angiogenic factors occurs in many biological processes, both physiological and pathological, among others in growth of primary solid malig